Innovo 208
by Atlantic Therapeutics, Ltd. 35 variants
Innovo 208 (0209-5006) is a Class II device made by Atlantic Therapeutics, Ltd., cleared under FDA 510(k) K192357 on 16 Jan 2020, granted FDA De Novo DEN170049 on 6 Nov 2018 and listed in FDA GUDID since 11 May 2021 (UDI-DI 15391533471156), active as of 23 Oct 2026.
Active
510(k) De Novo
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number15391533471156 | Date11 May 2021 | StatusListed |
| United States | FDA 510(k)SESE | NumberK192357 | Date16 Jan 2020 | StatusActive |
| United States | FDA De NovoDENG | NumberDEN170049 | Date6 Nov 2018 | StatusActive |
Official records
- AccessGUDID record 15391533471156
- FDA 510(k) database K192357
- FDA De Novo database DEN170049
Across registries
- FDA 510(k) K192357 decided 16 Jan 2020 Active
- FDA De Novo DEN170049 decided 6 Nov 2018 Active
- FDA GUDID UDI-DI 15391533471156 listed 11 May 2021 Listed
Timeline
- Granted FDA De Novo DEN170049
- Cleared FDA 510(k) K192357
- Listed FDA GUDID 15391533471156
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA De Novo, FDA 510(k) Active
Specification
- Trade name
- Innovo
- Generic name
- Electrode conductive medium
- Model / Ref / Catalog
- 208, 0209-5006
- Primary DI / UDI-DI
- 15391533471156
- 510(k) Number
- De Novo Number
- FDA product code
- QAJ
- GMDN term
- Electrode conductive medium
- Device class
- Class II
- Regulation number
- 876.5330
- GUDID distribution status
- In Commercial Distribution